EUGON HP 75IU INJECTION

Eugon HP 75IU Injection is a source of the active ingredient Menotrophin. This is an ovulation-stimulating agent which is part of the class of drugs known as gonadotropins. It is a pure mixture of follicle-stimulating hormone (FSH) and the luteinizing hormone (LH). These are hormones that males and females naturally produce. They assist the reproductive organs in functioning normally.
Eugon HP 75IU injection is used for treating infertility among women who aren’t ovulating and have a polycystic ovarian disorder or who have not had a response to treatment using a medication called clomiphene citrate. It can also assist multiple follicles and increase fertility for women undergoing IVF (in-vitro fertilization) or other forms that help in conception. It is also used to treat male infertility because of low sperm counts.
Do not use Eugon HP 75IU Injection if allergic to menotrophin or other medication ingredients. Don’t take this medication if you are suffering from an abnormal pituitary gland (a gland that is located at the bottom of your brain, which produces certain hormones, including the growth hormones) or in the hypothalamus (an area that is located beneath the brain’s thalamus called the thalamus that regulates the internal conditions of your body such as blood pressure and body temperature) as well as in your uterus, ovaries the testicles, and breasts and the prostate gland. Before starting treatment, you’ll be examined for thyroid issues, hormone levels, and tumors in the hypothalamus and pituitary glands.
Do not take this medication if you suffer from cysts in your ovary that aren’t caused by PCOD bleeding from the vagina and menopausal early onset, physical issues with these organs if your womb was removed, or if you are pregnant or nursing. Tell your physician right away if you experience any of these symptoms, including abdominal pain and swelling and weight increase, diarrhea, difficulties in breathing, or decreased frequency of urination. Inform your doctor if you are suffering from or have been diagnosed with liver problems or had a history of blood clotting disease before starting treatment.